Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

RPG Life Sciences Ltd

RPGLIFE.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: BUY

Last Close

$29.15

▼ -1.70%

Market Cap $482.15M · Vol 14.34K

Key Metrics

P/E Ratio

38.46

FWD: 32.23

Market Cap

$482.15M

Small Cap

Div Yield

0.86%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

37.46

Momentum

Beta

1.12

vs Market

52W High

$32.29

8.98% below

52W Low

$18.16

57.42% above

Volume

14.34K

Avg 38.57K

P/B

5.08

Price-to-book

ROE

N/A

Return on equity

Free Float

24.70%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, RPG Life Sciences Ltd (RPGLIFE.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does RPGLIFE.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+4.55%

+1.54%

+18.48%

+40.90%

YTD

+19.81%

+22.96%

+117.43%

+418.06%

Financials & Valuation

TTM · Annual

Total Revenue	$75.71M
Net Income	$12.32M
Revenue Growth (YoY)	+15.85%
Gross Margin	57.34%
Operating Margin	17.75%
Net Profit Margin	16.28%
ROE	N/A
ROA · ROIC	21.25% · 20.04%

P/E Ratio	38.46
Forward P/E (FY1)	32.23
PEG Ratio	-0.72
P/S	4.34
P/B	5.08
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	16.54M

Technical Indicators

50-Day SMA	$26.94
200-Day SMA	$23.63
RSI (14)	37.46
Beta	1.12
52-Week High	$32.29
52-Week Low	$18.16

Volume Today	14.34K
Avg Daily Volume (30D)	38.57K
Relative Volume	0.37x
Volatility (10D)	42.51
Volatility (30D)	52.01
Free Float	24.70%

Analyst Consensus

BUY

Current Price $29.15

Mean Target N/A

52W Low$18.16 52W High$32.29

Current

Target

$18.16 $32.29

Current Analyst target

· 1 analysts

Identifiers

ExchangeNSE India

FIGIBBG001T20KJ6

ISININE105J01010

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

RPG Life Sciences Limited is an India-based research-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations, and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has a presence in nephrology, oncology, rheumatology, cardiology, respiratory, pain management, vitamins & minerals, gastroenterology, and gynecology & pediatrics. The International Formulations business operates in the generics and branded generics space across Canada, Europe, Australia, New Zealand, and South America. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Quinfamide, Nicorandil, Haloperidol, Risperidone, Tolvaptan, Spironolactone, Sertraline, Naprosyn, Teristrong, and others.